We previously reported the use of cytidine base editing to develop “universal” donor CAR T cells (BE-CAR7) against CD7, a molecule expressed on T-cell acute lymphoblastic leukaemia (T-ALL) and present on a large proportion of healthy lymphocytes. The gene discussed is CD7; the disease is acute lymphoblastic leukemia.